1. 2 out of 5 real-world myeloma patients ineligible for clinical trials; 75% of frail patients ineligible.
ash.confex.com/ash/2019/webpr…
#GeriHemeList
2. Response rates in frail patients similar to those in intermediate or fit transplant-ineligible NDMM patients
ash.confex.com/ash/2019/webpr…
#GeriHemeList
3. Ixa-dara-dex in unfit/frail NDMM patients: ORR 80+%; few stopped therapy for toxicity
ash.confex.com/ash/2019/webpr…
#GeriHemeList
4. Stable to improved geriatric parameters in older adults with NDMM over 6-months.
COI disclosure: 1st author is my stellar mentee @HiraSMian ash.confex.com/ash/2019/webpr…
#GeriHemeList
@HiraSMian 5. @carevive electronic capture of frailty: correlates with CARG tox score. Arti's legacy continues...
COI disclosure: I’m privileged to be a part of this team!
ash.confex.com/ash/2019/webpr…
#GeriHemeList
@HiraSMian @carevive 6. Myeloma Risk Profile in transplant ineligible NDMM pts: age, PS, ISS and CRP. It won't make me drop geriatric assessment though!
ash.confex.com/ash/2019/webpr…
#GeriHemeList
@HiraSMian @carevive 7. Using @Krockdoc's Accumulation of Deficits Frailty Approach in older veterans with myeloma
COI disclosure: Dr. Patel is mentee of @KSanfilippoMD and me. Great work, Bindi!
ash.confex.com/ash/2019/webpr…
#GeriHemeList
@HiraSMian @carevive @Krockdoc @KSanfilippoMD 8. Comparing approaches to risk assessment in older adults with MM: RMCI, IMWG, CCI, Mayo and UK MRP. All prognostic, but different discrimination...
ash.confex.com/ash/2019/webpr…
#GeriHemeList
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.